Twilight of the (Consumer) Goods?

The investment rationale for staples stocks hasn't fundamentally altered, yet their market treatment has swung sharply. The narrative explaining why investors should own them shifted not because the underlying business conditions changed, but because broader market attention moved to different concerns. What happens when the same company gets evaluated through an entirely new interpretive frame?

• Rising costs used to be a defensive feature. Staples could pass through price increases and remain stable holdings. In 2018, that same pressure became the central reason to avoid them entirely.
• Growth expectations changed the entire calculus. As recession fears displaced inflation concerns in market discourse, the focus on these companies shifted from "steady income" to "can they grow at all," exposing vulnerabilities that were always there but never discussed.
• The narrative shift outpaced any actual business deterioration. Media and analyst coverage of rising costs jumped 45% and growth concerns 37% since 2015, but this reflected changing market conversation, not a sudden crisis in these businesses.
• Management teams responded to the new story, not the old business. Altria's major Juul investment, brewing companies announcing cannabis partnerships, acquisitions meant to signal growth. The companies were chasing the new narrative rather than defending the old one.
• If attention shifts again, does the valuation reset follow? The same fundamental characteristics that looked like strengths in one narrative environment look like fatal flaws in another. The stocks themselves haven't changed.